The peripheral nervous system is responsible for transmitting signals between the brain, spinal cord, and muscles. In dogs affected by DINGS2, the underlying genetic mutation interferes with the normal maintenance and function of these nerves. Over time, this leads to degeneration of nerve fibers, resulting in reduced communication between the nervous system and muscles, especially in the hind limbs.
Clinical signs of DINGS2 typically appear in young to adult dogs, depending on the severity of the mutation and breed predisposition. Early symptoms may include mild hind limb weakness, reduced stamina, or subtle changes in gait. As the condition progresses, affected dogs may develop more obvious neurological signs such as ataxia (uncoordinated movement), dragging of the hind limbs, and difficulty rising or climbing stairs.
Muscle wasting (atrophy) may also occur as a secondary effect due to reduced nerve stimulation of the muscles. Dogs may appear physically weaker despite normal muscle structure initially. Reflexes in the hind limbs may become reduced, and coordination gradually worsens over time.
In more advanced cases, DINGS2 can significantly affect mobility, with dogs struggling to walk long distances or maintain balance. However, cognitive function is typically unaffected, meaning dogs remain alert and responsive even as physical coordination declines.
The DINGS2 DNA Health Test is designed to detect the specific mutation responsible for this hereditary neuropathy. The test is simple, safe, and non-invasive, typically performed using a cheek swab or blood sample. The DNA is analyzed in a specialized laboratory to determine whether the dog carries zero, one, or two copies of the mutation. Because genetic information does not change throughout life, testing can be performed at any age, including before clinical signs appear.
Results are generally reported as:
- Clear (Normal): The dog does not carry the DINGS2 mutation and is not expected to develop or pass on the disorder.
- Carrier: The dog carries one copy of the mutation but typically does not show clinical signs. However, it can pass the mutation to offspring.
- Affected/At Risk: The dog carries two copies of the mutation and is expected to develop progressive neurological signs associated with DINGS2.
Genetic testing for DINGS2 is highly valuable for breeders, veterinarians, and dog owners. Breeders can use test results to avoid carrier-to-carrier matings, helping reduce the prevalence of this neurological condition in future generations while maintaining healthy genetic diversity.
For dog owners, knowing a dog’s genetic status allows for early monitoring and supportive care planning. While there is currently no cure for DINGS2, supportive management such as physiotherapy, controlled exercise, mobility assistance, and environmental adaptations can help maintain comfort and quality of life.
The DINGS2 Health Test is a reliable genetic screening tool that supports responsible breeding practices, promotes canine neurological health, and helps reduce the impact of this inherited peripheral nerve disorder in future generations.
